Ascletis Pharma Inc. (ASCLF) Financials
ASCLF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 360.9 million | 26.4 million |
| Dec. 31, 2025 | 295.5 million | 18.6 million |
| June 30, 2025 | 278.7 million | 18.0 million |
| March 31, 2025 | 274.9 million | 17.8 million |
ASCLF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | ? | ? |
| Dec. 31, 2025 | -29.5 million | ? |
| June 30, 2025 | -24.1 million | 535447 |
| March 31, 2025 | -11.9 million | 264067 |
ASCLF Net Income
No data available :(
ASCLF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 333.7 million | - | 220190 |
| Dec. 31, 2025 | 271.8 million | - | 737401 |
| June 30, 2025 | 251.4 million | - | 595608 |
| March 31, 2025 | 248.0 million | - | - |
ASCLF Shares Outstanding
ASCLF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | 49.2 million | 4.4 million | - |
| Dec. 31, 2025 | 81991 | 36.1 million | 4.1 million | - |
| June 30, 2025 | 20621 | 20.5 million | 6.0 million | - |
| March 31, 2025 | - | 10.1 million | 3.0 million | - |
ASCLF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | 1.3 million |
| Dec. 31, 2025 | 133106 | 1.2 million |
| June 30, 2025 | 150891 | 134001 |
| March 31, 2025 | 74415 | 66085 |
ASCLF
Price: $0.75
52 week price:
Earnings Per Share: -0.09 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 1.1 billion